Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis: Focus on Clinical Application, End User, Type, and Region - Analysis and Forecast, 2022-2031

Table of Contents

1 Markets

• 1.1 Global Market Outlook
  • 1.1.1 Product Definition
  • 1.1.2 Inclusion and Exclusion Criteria
  • 1.1.3 Key Findings
  • 1.1.4 Assumptions and Limitations
  • 1.1.5 Global Market Scenario
    • 1.1.5.1 Realistic Growth Scenario
    • 1.1.5.2 Optimistic Growth Scenario
    • 1.1.5.3 Pessimistic/Conservative Growth Scenario
• 1.2 Industry Outlook
  • 1.2.1 Key Trends
    • 1.2.1.1 Emerging Use of Wearables
    • 1.2.1.2 Growing Demand for Point-of-Care Testing (POCT) in Oncology
    • 1.2.1.3 Growing Popularity of Smartphone-Based Diagnostics
    • 1.2.1.4 Growing Demand for Minimally Invasive Methods of Cancer Diagnosis
    • 1.2.1.5 Rising Number of Partnerships and Regulatory Milestones
  • 1.2.2 Opportunity Assessment
    • 1.2.2.1 Short-Term Potential
    • 1.2.2.2 Long-Term Potential
  • 1.2.3 Patent Analysis
    • 1.2.3.1 Awaited Technological Developments
    • 1.2.3.2 Patent Filing Trend (by Country)
    • 1.2.3.3 Patent Filing Trend (by Year)
  • 1.2.4 Product Benchmarking
  • 1.2.5 End-User Perceptions
  • 1.2.6 Case Studies
    • 1.2.6.1 Stereotactic Body Radiation Therapy (SBRT) using TrueBeam for Inoperable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    • 1.2.6.2 Breast Cancer Treatment Using Halcyon
• 1.3 Impact of COVID-19 on the Next-Generation Oncology Devices and Solutions Market
  • 1.3.1 Impact on Adoption of Oncology Solutions
  • 1.3.2 Impact on Market Size
    • 1.3.2.1 Pre-COVID-19 Phase
    • 1.3.2.2 During COVID-19 Phase
    • 1.3.2.3 Post-COVID-19 Phase
  • 1.3.3 Market Entry Barriers and Opportunities
• 1.4 Business Dynamics
  • 1.4.1 Impact Analysis
  • 1.4.2 Business Drivers
    • 1.4.2.1 Increasing Prevalence of Oncology and a Growing Geriatric Population
    • 1.4.2.2 Increase in Demand for Software Solutions in Oncology
    • 1.4.2.3 Emerging Technologies in Oncology Testing and Treatment
    • 1.4.2.4 Rising Preference for Minimally Invasive Techniques of Diagnosis and Treatment
  • 1.4.3 Business Restraints
    • 1.4.3.1 Side Effects and Risks Associated with Cancer Treatment
    • 1.4.3.2 Dearth of Well-Trained and Skilled Professionals in Oncology
  • 1.4.4 Business Opportunities
    • 1.4.4.1 Increasing Demand for Home-Based Cancer Testing
    • 1.4.4.2 Growing Demand for Targeted Therapy

2 Global Next-Generation Oncology Devices and Solutions Market, (by Clinical Application)

• 2.1 Opportunity Assessment
• 2.2 Growth-Share Matrix
• 2.3 Lung Cancer
• 2.4 Prostate Cancer
• 2.5 Breast Cancer
• 2.6 Others

3 Global Next-Generation Oncology Devices and Solutions Market (by End User)

• 3.1 Opportunity Assessment
• 3.2 Growth-Share Matrix
• 3.3 Hospitals
• 3.4 Diagnostic Imaging Centers
• 3.5 Others (Ambulatory Surgical Centers, Cancer Care Centers, and Government Institutions)

4 Global Next-Generation Oncology Devices and Solutions Market (by Type)

• 4.1 Opportunity Assessment
• 4.2 Growth-Share Matrix
• 4.3 Devices
  • 4.3.1 By Technology
    • 4.3.1.1 High-Intensity Focused Ultrasound
    • 4.3.1.2 Advanced Forms of Radiation Therapy
    • 4.3.1.3 Others
  • 4.3.2 By Application
    • 4.3.2.1 Diagnosis
    • 4.3.2.2 Treatment and Monitoring
• 4.4 Software
  • 4.4.1 By Application
    • 4.4.1.1 Diagnosis
    • 4.4.1.2 Treatment and Monitoring

5 Region

• 5.1 North America Next-Generation Oncology Devices and Solutions Market
  • 5.1.1 Key Findings and Opportunity Assessment
  • 5.1.2 Regulatory Framework
  • 5.1.3 Key Players in North America
  • 5.1.4 Market Dynamics
    • 5.1.4.1 Impact Analysis
  • 5.1.5 Sizing and Forecast Analysis
    • 5.1.5.1 North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
    • 5.1.5.2 North America Next-Generation Oncology Devices and Solutions Market (by End User)
    • 5.1.5.3 North America Next-Generation Oncology Devices and Solutions Market (by Type)
      • 5.1.5.3.1 North America Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
      • 5.1.5.3.2 North America Next-Generation Oncology Devices and Solutions Market, Device (by Application)
      • 5.1.5.3.3 North America Next-Generation Oncology Devices and Solutions Market, Software (by Application)
    • 5.1.5.4 North America Next-Generation Oncology Devices and Solutions Market (by Country)
      • 5.1.5.4.1 U.S.
        • 5.1.5.4.1.1 Market Dynamics
        • 5.1.5.4.1.2 Sizing and Forecast Analysis
        • 5.1.5.4.1.3 U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.1.5.4.1.4 U.S. Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.1.5.4.2 Canada
        • 5.1.5.4.2.1 Market Dynamics
        • 5.1.5.4.2.2 Sizing and Forecast Analysis
        • 5.1.5.4.2.3 Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.1.5.4.2.4 Canada Next-Generation Oncology Devices and Solutions Market (by End User)
• 5.2 Europe Next-Generation Oncology Devices and Solutions Market
  • 5.2.1 Key Findings and Opportunity Assessment
  • 5.2.2 Regulatory Framework
  • 5.2.3 Key Players in Europe
  • 5.2.4 Market Dynamics
    • 5.2.4.1 Impact Analysis
  • 5.2.5 Sizing and Forecast Analysis
    • 5.2.5.1 Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
    • 5.2.5.2 Europe Next-Generation Oncology Devices and Solutions Market (by End User)
    • 5.2.5.3 Europe Next-Generation Oncology Devices and Solutions Market (by Type)
      • 5.2.5.3.1 Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
      • 5.2.5.3.2 Europe Next-Generation Oncology Devices and Solutions Market, Device (by Application)
      • 5.2.5.3.3 Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application)
    • 5.2.5.4 Europe Next-Generation Oncology Devices and Solutions Market (by Country)
      • 5.2.5.4.1 Germany
        • 5.2.5.4.1.1 Market Dynamics
        • 5.2.5.4.1.2 Sizing and Forecast Analysis
        • 5.2.5.4.1.2.1 Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.2.5.4.1.2.2 Germany Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.2.5.4.2 U.K.
        • 5.2.5.4.2.1 Market Dynamics
        • 5.2.5.4.2.2 Sizing and Forecast Analysis
        • 5.2.5.4.2.2.1 U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.2.5.4.2.2.2 U.K. Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.2.5.4.3 France
        • 5.2.5.4.3.1 Market Dynamics
        • 5.2.5.4.3.2 Sizing and Forecast Analysis
        • 5.2.5.4.3.2.1 France Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.2.5.4.3.2.2 France Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.2.5.4.4 Italy
        • 5.2.5.4.4.1 Market Dynamics
        • 5.2.5.4.4.2 Sizing and Forecast Analysis
        • 5.2.5.4.4.2.1 Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.2.5.4.4.2.2 Italy Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.2.5.4.5 Spain
        • 5.2.5.4.5.1 Market Dynamics
        • 5.2.5.4.5.2 Sizing and Forecast Analysis
        • 5.2.5.4.5.2.1 Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.2.5.4.5.2.2 Spain Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.2.5.4.6 Rest-of-Europe
        • 5.2.5.4.6.1 Market Dynamics
        • 5.2.5.4.6.2 Sizing and Forecast Analysis
        • 5.2.5.4.6.2.1 Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.2.5.4.6.2.2 Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User)
• 5.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market
  • 5.3.1 Key Findings and Opportunity Assessment
  • 5.3.2 Regulatory Framework
  • 5.3.3 Key Players in Asia-Pacific
  • 5.3.4 Market Dynamics
    • 5.3.4.1 Impact Analysis
  • 5.3.5 Sizing and Forecast Analysis
    • 5.3.5.1 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
    • 5.3.5.2 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User)
    • 5.3.5.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type)
      • 5.3.5.3.1 Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
      • 5.3.5.3.2 Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Device (by Application)
      • 5.3.5.3.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by Application)
    • 5.3.5.4 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country)
      • 5.3.5.4.1 Japan
        • 5.3.5.4.1.1 Market Dynamics
        • 5.3.5.4.1.2 Sizing and Forecast Analysis
        • 5.3.5.4.1.2.1 Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.3.5.4.1.2.2 Japan Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.3.5.4.2 China
        • 5.3.5.4.2.1 Market Dynamics
        • 5.3.5.4.2.2 Sizing and Forecast Analysis
        • 5.3.5.4.2.2.1 China Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.3.5.4.2.2.2 China Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.3.5.4.3 Australia
        • 5.3.5.4.3.1 Market Dynamics
        • 5.3.5.4.3.2 Sizing and Forecast Analysis
        • 5.3.5.4.3.2.1 Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.3.5.4.3.2.2 Australia Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.3.5.4.4 India
        • 5.3.5.4.4.1 Market Dynamics
        • 5.3.5.4.4.2 Sizing and Forecast Analysis
        • 5.3.5.4.4.2.1 India Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.3.5.4.4.2.2 India Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.3.5.4.5 South Korea
        • 5.3.5.4.5.1 Market Dynamics
        • 5.3.5.4.5.2 Sizing and Forecast Analysis
        • 5.3.5.4.5.2.1 South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.3.5.4.5.2.2 South Korea Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.3.5.4.6 Rest-of-Asia-Pacific
        • 5.3.5.4.6.1 Market Dynamics
        • 5.3.5.4.6.2 Sizing and Forecast Analysis
        • 5.3.5.4.6.2.1 Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.3.5.4.6.2.2 Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User)
• 5.4 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market
  • 5.4.1 Key Findings and Opportunity Assessment
  • 5.4.2 Regulatory Framework
  • 5.4.3 Key Players in Rest-of-the-World
  • 5.4.4 Market Dynamics
    • 5.4.4.1 Impact Analysis
  • 5.4.5 Sizing and Forecast Analysis
    • 5.4.5.1 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
    • 5.4.5.2 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User)
    • 5.4.5.3 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type)
      • 5.4.5.3.1 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
      • 5.4.5.3.2 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Device (by Application)
      • 5.4.5.3.3 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by Application)
    • 5.4.5.4 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country)
      • 5.4.5.4.1 Kingdom of Saudi Arabia (K.S.A.)
        • 5.4.5.4.1.1 Market Dynamics
        • 5.4.5.4.1.2 Sizing and Forecast Analysis
        • 5.4.5.4.1.2.1 K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.4.5.4.1.2.2 K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.4.5.4.2 Brazil
        • 5.4.5.4.2.1 Market Dynamics
        • 5.4.5.4.2.2 Sizing and Forecast Analysis
        • 5.4.5.4.2.2.1 Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.4.5.4.2.2.2 Brazil Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.4.5.4.3 U.A.E.
        • 5.4.5.4.3.1 Market Dynamics
        • 5.4.5.4.3.2 Sizing and Forecast Analysis
        • 5.4.5.4.3.2.1 U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.4.5.4.3.2.2 U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.4.5.4.4 Mexico
        • 5.4.5.4.4.1 Market Dynamics
        • 5.4.5.4.4.2 Sizing and Forecast Analysis
        • 5.4.5.4.4.2.1 Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.4.5.4.4.2.2 Mexico Next-Generation Oncology Devices and Solutions Market (by End User)
      • 5.4.5.4.5 Rest-of-Rest-of-the-World
        • 5.4.5.4.5.1 Market Dynamics
        • 5.4.5.4.5.2 Sizing and Forecast Analysis
        • 5.4.5.4.5.2.1 Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
        • 5.4.5.4.5.2.2 Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User)

6 Markets - Competitive Benchmarking

• 6.1 Competitive Landscape
  • 6.1.1 Key Strategies and Developments
    • 6.1.1.1 Regulatory and Legal Activities
    • 6.1.1.2 Partnerships, Alliances, and Business Expansions
    • 6.1.1.3 New Offerings
    • 6.1.1.4 Mergers and Acquisitions
    • 6.1.1.5 Funding Activities
• 6.2 Market Share Analysis

List of Figures

• Figure 1: Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis
• Figure 2: Global Next-Generation Oncology Devices and Solutions Market (by Region), $Million, 2021 and 2031
• Figure 3: Global Next-Generation Oncology Devices and Solutions Market Segmentation
• Figure 4: Global Next-Generation Oncology Devices and Solutions Market Research Methodology
• Figure 5: Primary Research
• Figure 6: Secondary Research
• Figure 7: Data Triangulation
• Figure 8: Global Next-Generation Oncology Devices and Solutions Market Research Process
• Figure 9: Assumptions and Limitations
• Figure 10: Global Next-Generation Oncology Devices and Solutions Market, Potential Forecast Scenarios
• Figure 11: Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031
• Figure 12: Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031
• Figure 13: Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Pessimistic/Conservative Scenario), $Million, 2020-2031
• Figure 14: Global Next-Generation Oncology Devices and Solutions Market Key Trends, Short-Term Potential
• Figure 15: Global Next-Generation Oncology Devices and Solutions Market Key Trends, Long-Term Potential
• Figure 16: Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Country), January 2018-April 2022
• Figure 17: Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Year), January 2018-April 2022
• Figure 18: Key Players' Product Offerings (by Type)
• Figure 19: Global Next-Generation Oncology Devices and Solutions Market, Pre-COVID-19 Phase, $Million, 2020-2031
• Figure 20: Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis
• Figure 21: Global Number of New Cases for All Cancers, 2020-2040
• Figure 22: Global Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
• Figure 23: Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Clinical Application), $Million, 2021-2031
• Figure 24: Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by Clinical Application), 2021-2031
• Figure 25: Global Next-Generation Oncology Devices and Solutions Market (Lung Cancer), $Million, 2020-2031
• Figure 26: Global Next-Generation Oncology Devices and Solutions Market (Prostate Cancer), $Million, 2020-2031
• Figure 27: Global Next-Generation Oncology Devices and Solutions Market (Breast Cancer), $Million, 2020-2031
• Figure 28: Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
• Figure 29: Global Next-Generation Oncology Devices and Solutions Market (by End User)
• Figure 30: Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by End User), $Million, 2021-2031
• Figure 31: Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by End User), 2021-2031
• Figure 32: Global Next-Generation Oncology Devices and Solutions Market (Hospitals), $Million, 2020-2031
• Figure 33: Global Next-Generation Oncology Devices and Solutions Market (Diagnostic Imaging Centers), $Million, 2020-2031
• Figure 34: Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
• Figure 35: Global Next-Generation Oncology Devices and Solutions Market (by Type)
• Figure 36: Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Type), $Million, 2021-2031
• Figure 37: Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by Type), 2021-2031
• Figure 38: Global Next-Generation Oncology Devices and Solutions Market (High-Intensity Focused Ultrasound), $Million, 2020-2031
• Figure 39: Global Next-Generation Oncology Devices and Solutions Market (Advanced Forms of Radiation Therapy), $Million, 2020-2031
• Figure 40: Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
• Figure 41: Global Next-Generation Oncology Devices and Solutions Market, Devices (Diagnosis), $Million, 2020-2031
• Figure 42: Global Next-Generation Oncology Devices and Solutions Market, Devices (Treatment and Monitoring), $Million, 2020-2031
• Figure 43: Global Next-Generation Oncology Devices and Solutions Market, Software (Diagnosis), $Million, 2020-2031
• Figure 44: Global Next-Generation Oncology Devices and Solutions Market, Software (Treatment and Monitoring), $Million, 2020-2031
• Figure 45: Global Next-Generation Oncology Devices and Solutions Market Share (by Region), 2021-2031
• Figure 46: North America Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
• Figure 47: Prevalence of Different Cancer in North America, 2010, 2015, and 2019
• Figure 48: Number of New Cases for All Cancers in North America, 2020-2040
• Figure 49: North America Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 50: North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 51: North America Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 52: North America Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
• Figure 53: North America Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
• Figure 54: North America Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
• Figure 55: North America Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
• Figure 56: North America Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
• Figure 57: U.S. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 58: U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 59: U.S. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 60: Canada Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 61: Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 62: Canada Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 63: Europe Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
• Figure 64: Number of New Cases for All Cancers in Europe, 2020-2040
• Figure 65: Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 66: Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 67: Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 68: Europe Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
• Figure 69: Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
• Figure 70: Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
• Figure 71: Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
• Figure 72: Europe Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
• Figure 73: Germany Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 74: Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 75: Germany Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 76: U.K. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 77: U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 78: U.K. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 79: France Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 80: France Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 81: France Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 82: Italy Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 83: Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 84: Italy Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 85: Spain Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 86: Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 87: Spain Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 88: Rest-of-Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 89: Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 90: Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 91: Asia-Pacific Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
• Figure 92: Prevalence of Different Cancer in Asia-Pacific, 2010, 2015, and 2019
• Figure 93: Number of New Cases for All Cancers in Asia-Pacific, 2020-2040
• Figure 94: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 95: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 96: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 97: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
• Figure 98: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
• Figure 99: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
• Figure 100: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
• Figure 101: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
• Figure 102: Japan Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 103: Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 104: Japan Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 105: China Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 106: China Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 107: China Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 108: Australia Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 109: Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 110: Australia Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 111: India Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 112: India Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 113: India Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 114: South Korea Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 115: South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 116: South Korea Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 117: Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 118: Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 119: Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 120: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
• Figure 121: Number of New Cases for All Cancers in Africa and Latin America, 2020-2040
• Figure 122: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 123: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 124: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 125: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
• Figure 126: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
• Figure 127: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
• Figure 128: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
• Figure 129: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
• Figure 130: K.S.A. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 131: K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 132: K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 133: Brazil Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 134: Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 135: Brazil Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 136: U.A.E. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 137: U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 138: U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 139: Mexico Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 140: Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 141: Mexico Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 142: Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
• Figure 143: Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
• Figure 144: Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
• Figure 145: Share of Key Developments and Strategies, January 2018-April 2022
• Figure 146: Regulatory and Legal Activities (by Company), January 2018-April 2022
• Figure 147: Partnerships, Alliances, and Business Expansions (by Company), January 2018-April 2022
• Figure 148: New Offerings (by Company), January 2018-April 2022
• Figure 149: Mergers and Acquisitions (by Company), January 2018-April 2022
• Figure 150: Funding Activities (by Company), January 2018-April 2022
• Figure 151: Global Next-Generation Oncology Devices and Solutions Market, Company Revenue Share Analysis, $Million, 2021

List of Tables

• Table 1: Global Next-Generation Oncology Devices and Solutions Market, Quarterly Key Developments Analysis, January 2018-April 2022
• Table 2: Global Next-Generation Oncology Devices and Solutions Market, Key Entry Barriers and Possible Solutions
• Table 3: Key Software Solutions in Oncology
• Table 4: Key Technologies and Products in Oncology for Diagnosis and Treatment
• Table 5: Key Players Offering HIFU Devices for Cancer
• Table 6: Key Products Based on IGRT and IMRT Technology
• Table 7: Key Players Offering Next-Generation Oncology Devices for Diagnosis
• Table 8: Key Players Offering Next-Generation Oncology Devices for Treatment and Monitoring of Cancer
• Table 9: Key Players Offering Next-Generation Oncology Software for Diagnosis
• Table 10: Key Players Offering Next-Generation Oncology Software for Treatment and Monitoring
• Table 11: North America Next-Generation Oncology Devices and Solutions Market Regulatory Framework
• Table 12: U.S. Next-Generation Oncology Devices and Solutions Market, Key Players and Product Offering
• Table 13: North America Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
• Table 14: Key Players in France Next-Generation Oncology Devices and Software Market
• Table 15: Key Players in Rest-of-Europe Next-Generation Oncology Devices and Solutions Market
• Table 16: Europe Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
• Table 17: Asia-Pacific Next-Generation Oncology Devices and Solutions Market Regulatory Framework
• Table 18: Asia-Pacific Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
• Table 19: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Regulatory Framework
• Table 20: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis